More data emerge on progestin-only birth control, as FDA mulls OTC switch

In the News

Dec 1

Written By Leah Scott

A research study conducted by Ibis Reproductive Health was cited in this article covering the efficacy of progestin-only birth control pills as the FDA reviews HRA Pharma’s application for Opill.

contraceptive useFDAOTC accessprogestin-only pillssafety and efficacy

Leah Scott

Q&A: Survey supports OTC progestin-only pill availability to increase contraceptive access

America, it’s time to free the pill